Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2020 Jul 26

PMID 32707666

Citations 112

Authors

Esra Kupeli Akkol

Yasin Genc

Busra Karpuz

Eduardo Sobarzo-Sanchez

Raffaele Capasso

Affiliations

Soon will be listed here.

Abstract

Cancer is one of the most common causes of disease-related deaths worldwide. Despite the discovery of many chemotherapeutic drugs that inhibit uncontrolled cell division processes for the treatment of various cancers, serious side effects of these drugs are a crucial disadvantage. In addition, multi-drug resistance is another important problem in anticancer treatment. Due to problems such as cytotoxicity and drug resistance, many investigations are being conducted to discover and develop effective anticancer drugs. In recent years, researchers have focused on the anticancer activity coumarins, due to their high biological activity and low toxicity. Coumarins are commonly used in the treatment of prostate cancer, renal cell carcinoma and leukemia, and they also have the ability to counteract the side effects caused by radiotherapy. Both natural and synthetic coumarin derivatives draw attention due to their photochemotherapy and therapeutic applications in cancer. In this review, a compilation of various research reports on coumarins with anticancer activity and investigation and a review of structure-activity relationship studies on coumarin core are presented. Determination of important structural features around the coumarin core may help researchers to design and develop new analogues with a strong anticancer effect and reduce the potential side effects of existing therapeutics.

Citing Articles

A Computational Approach to Predictive Modeling Using Connection-Based Topological Descriptors: Applications in Coumarin Anti-Cancer Drug Properties.

Hayat S, Wazzan S Int J Mol Sci. 2025; 26(5).

PMID: 40076454 PMC: 11899830. DOI: 10.3390/ijms26051827.

biosynthesis of 4,6-dihydroxycoumarin in .

Gan Q, Jiang T, Li C, Gong X, Zhang J, Desai B Green Chem. 2025; 27(11):3064-3076.

PMID: 40013057 PMC: 11848710. DOI: 10.1039/d4gc05694a.

Immunomodulatory Effects of Selected Non-Nutritive Bioactive Compounds and Their Role in Optimal Nutrition.

Napiorkowska-Baran K, Treichel P, Dardzinska A, Majcherczak A, Pilichowicz A, Szota M Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996810 PMC: 11854453. DOI: 10.3390/cimb47020089.

Elucidating the Mechanism of Coumarin Homodimerization Using 3-Acetylcoumarin Derivatives.

Simeonova K, Koleva A, Petkova-Yankova N, Zlatanova A, Lozanova V, Nikolova R Molecules. 2025; 30(3).

PMID: 39942755 PMC: 11820059. DOI: 10.3390/molecules30030651.

Microtubule inhibition as a proposed mechanism for the anthelmintic effect of phytochemicals isolated from Cicerbita alpina.

Horgan M, Sigg I, Poulopoulou I, Rodriguez-Mejias F, Albertini E, Fusani P Sci Rep. 2025; 15(1):4108.

PMID: 39900941 PMC: 11791071. DOI: 10.1038/s41598-024-73958-9.

References

Rigel D, Friedman R, Kopf A . The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol. 1996; 34(5 Pt 1):839-47. DOI: 10.1016/s0190-9622(96)90041-9. View

Lake B . Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. Food Chem Toxicol. 1999; 37(4):423-53. DOI: 10.1016/s0278-6915(99)00010-1. View

Pan L, Chai H, Kinghorn A . The continuing search for antitumor agents from higher plants. Phytochem Lett. 2010; 3(1):1-8. PMC: 2836022. DOI: 10.1016/j.phytol.2009.11.005. View

Gotteland M, May E, Contesso G, DELARUE J, Mouriesse H . Estrogen receptors (ER) in human breast cancer. The significance of a new prognostic factor based on both ER protein and ER mRNA contents. Cancer. 1994; 74(3):864-71. DOI: 10.1002/1097-0142(19940801)74:3<864::aid-cncr2820740312>3.0.co;2-n. View

Ginsberg J, Hirsh J . Use of antithrombotic agents during pregnancy. Chest. 1992; 102(4 Suppl):385S-390S. DOI: 10.1378/chest.102.4_supplement.385s. View

Anderson W, Rosenberg P, Prat A, Perou C, Sherman M . How many etiological subtypes of breast cancer: two, three, four, or more?. J Natl Cancer Inst. 2014; 106(8). PMC: 4148600. DOI: 10.1093/jnci/dju165. View

Cox D, OKennedy R, Thornes R . The rarity of liver toxicity in patients treated with coumarin (1,2-benzopyrone). Hum Toxicol. 1989; 8(6):501-6. DOI: 10.1177/096032718900800612. View

Kokron O, Maca S, Gasser G, SCHMIDT P . Cimetidine and coumarin therapy of renal cell carcinoma. A pilot study. Oncology. 1991; 48(2):102-6. DOI: 10.1159/000226905. View

Wang C, Hsieh Y, Chu C, Lin Y, Tseng T . Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin. Cancer Lett. 2002; 183(2):163-8. DOI: 10.1016/s0304-3835(02)00031-9. View

10.

Agarwal R . Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem Pharmacol. 2000; 60(8):1051-9. DOI: 10.1016/s0006-2952(00)00385-3. View

11.

Ohren J, Chen H, Pavlovsky A, Whitehead C, Zhang E, Kuffa P . Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition. Nat Struct Mol Biol. 2004; 11(12):1192-7. DOI: 10.1038/nsmb859. View

12.

Putti T, Abd El-Rehim D, Rakha E, Paish C, Lee A, Pinder S . Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis. Mod Pathol. 2004; 18(1):26-35. DOI: 10.1038/modpathol.3800255. View

13.

Dempsey E, OSullivan C, Smyth M, Egan D, OKennedy R, Wang J . Development of an antibody-based amperometric biosensor to study the reaction of 7-hydroxycoumarin with its specific antibody. Analyst. 1993; 118(4):411-3. DOI: 10.1039/an9931800411. View

14.

Kattimani P, Kamble R, Kariduraganavar M, Dorababu A, Hunnur R . Synthesis, characterization and in vitro anticancer evaluation of novel 1,2,4-triazolin-3-one derivatives. Eur J Med Chem. 2013; 62:232-40. DOI: 10.1016/j.ejmech.2013.01.004. View

15.

Kostova I, Raleva S, Genova P, Argirova R . Structure-Activity Relationships of Synthetic Coumarins as HIV-1 Inhibitors. Bioinorg Chem Appl. 2007; :68274. PMC: 1686293. DOI: 10.1155/BCA/2006/68274. View

16.

Mickisch G . Urologic approaches to metastatic renal cell carcinoma. Onkologie. 2001; 24(2):122-6. DOI: 10.1159/000050298. View

17.

Jantamat P, Weerapreeyakul N, Puthongking P . Cytotoxicity and Apoptosis Induction of Coumarins and Carbazole Alkaloids from . Molecules. 2019; 24(18). PMC: 6767265. DOI: 10.3390/molecules24183385. View

18.

Cui N, Lin D, Shen Y, Shi J, Wang B, Zhao M . Triphenylethylene-Coumarin Hybrid TCH-5c Suppresses Tumorigenic Progression in Breast Cancer Mainly Through the Inhibition of Angiogenesis. Anticancer Agents Med Chem. 2019; 19(10):1253-1261. DOI: 10.2174/1871520619666190404155230. View

19.

Hamelers I, Van Schaik R, Sussenbach J, Steenbergh P . 17beta-Estradiol responsiveness of MCF-7 laboratory strains is dependent on an autocrine signal activating the IGF type I receptor. Cancer Cell Int. 2003; 3(1):10. PMC: 169177. DOI: 10.1186/1475-2867-3-10. View

20.

Bogan D, Deasy B, OKennedy R, Smyth M, Fuhr U . Determination of free and total 7-hydroxycoumarin in urine and serum by capillary electrophoresis. J Chromatogr B Biomed Appl. 1995; 663(2):371-8. DOI: 10.1016/0378-4347(94)00444-a. View